Gathering life energy
Caring for human health
Securities code：603520
The company's non-public offering project passed the meeting smoothly!
2020-06-12
On June 12, the 92nd working meeting of the 18th Issuance Review Committee of the China Securities Regulatory Commission in 2020 reviewed the company's application for non-public stock offerings. According to the review results, the company's application for non-public issuance of shares was approved.
Related news
Copyright © Zhejiang Starry Pharmaceutical Co., Ltd. All Rights Reserved.
Powered by www.300.cn
Wap
CONTACT US
Tel: 0576-87718628 / 021-37916067
E-mail: sales@starrypharma.com
Zhejiang Starry Pharmaceutical Co., Ltd.
Add: No.l Starry Road of Xianju, Modern IndustriaL, Centralization Zone, Xianju, Zhejiang, China
Shanghai Starry Pharmaceutical Co., Ltd.
Add: No.500 Maoye Road,Jinshan District 201506, Shanghai city, China
Zhejiang Taizhou Hisyn Pharmaceutical Co., Ltd.
Add: Chemical and Medical Raw Materials Base, Linhai Park, Zhejiang, China
Jiangxi Starry Pharmaceutical Co., Ltd.
Add: North of the Wuyl Road,Salt chemical Base, Zhangshu, Jiangxi, 331200, P.R.China
Imax Diagnostic Imaging Limited
Add: Phoenix House, Room 137 Monahan Road, CorkT12H1XY Republic of lreland
E-mail:info@imaxdiagnostic.com
Tel: 00353 21 451 9990
REQUEST A QUOTE
